Menu

European Measles Cases Quadrupled in 2017

The increase is attributed to a drop in immunization rates.

Feb 20, 2018
Shawna Williams

ISTOCK, ALMIR1968There were 21,315 measles cases reported across Europe in 2017, four times as many as the previous year, the World Health Organization (WHO) announced yesterday (February 19). Of the people diagnosed in Europe, 35 died of the disease, which struck hardest in Romania, Italy, and Ukraine.

“Every new person affected by measles in Europe reminds us that unvaccinated children and adults, regardless of where they live, remain at risk of catching the disease and spreading it to others who may not be able to get vaccinated,” says Zsuzsanna Jakab, WHO Regional Director for Europe, in the WHO statement. The cases and deaths “are a tragedy we simply cannot accept,” she adds.

The announcement came ahead of a meeting of health ministers to discuss how to achieve goals set out in the European Vaccine Action Plan. Those include the elimination of measles and rubella.

NBC notes that measles is highly infectious, affecting 90 percent of unvaccinated people exposed to it, and that to control the disease, 95 percent of a population must either be immunized or previously infected with the virus. In Italy, the outlet reports, vaccination rates had fallen to 85 percent in 2015.

The US Centers for Disease Control and Prevention last year warned international travelers to ensure they are vaccinated against measles.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.